SearchDictionaryMobileLogin

Wei Zheng Selected Research

Breast Neoplasms (Breast Cancer)

09/2008Vitamin supplement use and risk for breast cancer: the Shanghai Breast Cancer Study.
08/2008Association of Mitochondrial DNA Displacement Loop (CA)n Dinucleotide Repeat Polymorphism with Breast Cancer Risk and Survival among Chinese Women.
04/2008Quantitative analysis of mitochondrial DNA 4977-bp deletion in sporadic breast cancer and benign breast diseases.
01/2008IGF-I and IGF-II genetic variation and breast cancer risk in Chinese women: results from the Shanghai Breast Cancer Study.
01/2008Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study.
11/2007Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.
09/2007Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
06/2007Haplotype analysis of CYP11A1 identifies promoter variants associated with breast cancer risk.
05/2007Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
05/2007Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
01/2007Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review.
01/2007IGFBP3 mRNA expression in benign and malignant breast tumors.
01/2007Energy balance, insulin resistance biomarkers, and breast cancer risk.
10/2006Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival.
06/2006Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
06/2006Association of physical activity with hormone receptor status: the Shanghai Breast Cancer Study.
04/2006Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
11/2005Modifying effects of sulfotransferase 1A1 gene polymorphism on the association of breast cancer risk with body mass index or endogenous steroid hormones.
06/2005Association of genetic polymorphisms in the VEGF gene with breast cancer survival.
05/2005Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
05/2005MTHFR genotypes and breast cancer survival after surgery and chemotherapy: a report from the Shanghai Breast Cancer Study.
02/2005Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
02/2005Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.
01/2005Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women.
01/2005Genetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai Breast Cancer Study.
01/2005Association of cyclin D1 genotype with breast cancer risk and survival.
12/2004Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer.
09/2004Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis.
08/2004Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
08/2004Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
07/2004Passive smoking and breast cancer risk among non-smoking Chinese women.
06/2004Use of complementary and alternative medicine by chinese women with breast cancer.
06/2004Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer.
04/2004Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women.
02/2004[Expression of tyrosine kinase Syk in breast cancer and their clinical significance]
02/2004Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study.
01/2004Genetic polymorphism in the manganese superoxide dismutase gene, antioxidant intake, and breast cancer risk: results from the Shanghai Breast Cancer Study.
01/2004Insulin-like growth factor-I, soy protein intake, and breast cancer risk.
11/2003Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.
10/2003Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
09/2003Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
09/2003Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
07/2003Urinary isothiocyanate levels, brassica, and human breast cancer.
06/2003Intake of fruits, vegetables and selected micronutrients in relation to the risk of breast cancer.
06/2003Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
05/2003Plasma sex steroid hormones and breast cancer risk in Chinese women.
01/2003Dietary calcium intake and breast cancer risk among Chinese women in Shanghai.
01/2003Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.
09/2002Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai.
08/2002Insulin-like growth factors and breast cancer risk in Chinese women.

Articles by Research Topic

Disease

50Breast Neoplasms (Breast Cancer)
09/2008 - 08/2002
9Endometrial Neoplasms (Endometrial Cancer)
06/2008 - 05/2003
4Essential Tremor (Essential Tremors)
09/2008 - 08/2007
4Neoplasms (Cancer)
09/2008 - 10/2002
4Endometriosis (Adenomyosis)
06/2008 - 12/2007
3Hypertension (High Blood Pressure)
05/2008 - 10/2004
3Carcinoma (Carcinomatosis)
11/2007 - 02/2004
3Colorectal Neoplasms (Colorectal Cancer)
06/2007 - 11/2006
2Hemorrhagic Shock
01/2008 - 12/2006
2Gaucher Disease (Gaucher's Disease)
11/2007 - 08/2007
2Chronic Obstructive Pulmonary Disease (COPD)
04/2007 - 08/2005
2Adenoma (Adenomas)
01/2007 - 09/2006
2Insulin Resistance
01/2007 - 02/2004
2Prostatic Neoplasms (Prostate Cancer)
11/2006 - 10/2006
2DNA Damage
06/2005 - 08/2003
1Obesity
06/2008
1Breast Diseases (Breast Disease)
04/2008
1Ureteral Obstruction
12/2007
1Type 2 Diabetes Mellitus (MODY)
11/2007
1Syndrome
11/2007
1Chronic Hepatitis B
03/2007
1Myocardial Infarction
01/2007
1Parkinsonian Disorders (Parkinsonism)
06/2006
1Sepsis (Septicemia)
05/2006
1Choriocarcinoma
02/2005
1Stroke (Strokes)
02/2005

Drug/Important Bio-Agent (IBA)

7Estrogens (Estrogen)FDA Link
03/2008 - 01/2003
4harman (harmane)IBA
09/2008 - 08/2007
4Insulin-Like Growth Factor I (IGF-1)IBA
01/2008 - 01/2004
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2007 - 02/2005
3Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
05/2007 - 02/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007 - 06/2005
3Somatomedins (Somatomedin)IBA
02/2004 - 08/2002
2Mitochondrial DNA (mtDNA)IBA
08/2008 - 04/2008
2Biological Markers (Surrogate Marker)IBA
06/2008 - 01/2007
2indoleIBA
05/2008 - 03/2008
2Focal Adhesion Protein-Tyrosine KinasesIBA
05/2008 - 03/2008
2Superoxide DismutaseIBA
01/2008 - 01/2004
2TeaIBA
12/2007 - 06/2007
2Glutathione (Reduced Glutathione)IBA
12/2007 - 09/2004
2Glucosylceramidase (Glucocerebrosidase)IBA
11/2007 - 08/2007
2Sex Hormone-Binding GlobulinIBA
04/2007 - 05/2005
2MicronutrientsIBA
12/2006 - 06/2003
2Cyclin D1IBA
09/2006 - 01/2005
2HormonesIBA
06/2006 - 11/2005
2MutagensIBA
06/2005 - 08/2003
2Tobacco Smoke Pollution (Passive Smoking)IBA
02/2005 - 07/2004
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2004 - 05/2003
2Gonadal Steroid Hormones (Sex Hormones)IBA
04/2004 - 05/2003
2Estrogen Receptor alphaIBA
09/2003 - 09/2003
2Phytoestrogens (Phytoestrogen)IBA
06/2003 - 09/2002
1VitaminsIBA
09/2008
1C-Reactive ProteinIBA
06/2008
1Estradiol (Estrace)FDA LinkGeneric
05/2008
1angiotensin converting enzyme 2IBA
05/2008
1Malondialdehyde (Propanedial)IBA
01/2008
1IronIBA
01/2008
1Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2008
1Hydroxyproline (4 Hydroxyproline)IBA
12/2007
1Dietary Carbohydrates (Carbohydrate, Dietary)IBA
11/2007
1Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
11/2007
1Insulin (Novolin)FDA Link
09/2007
1Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA
06/2007
1Aromatase (CYP19)IBA
05/2007
1DNA (Deoxyribonucleic Acid)IBA
03/2007
1Hepatitis B e AntigensIBA
03/2007
1Messenger RNA (mRNA)IBA
01/2007
1CalciumIBA
12/2006
1CarnosineIBA
12/2006
1Cadherins (E-Cadherin)IBA
11/2006
1Dinoprostone (PGE2)FDA Link
11/2006
1Plasminogen Activators (Plasminogen Activator)IBA
10/2006
1Chromogranin AIBA
10/2006
1Prostate-Specific Antigen (Semenogelase)IBA
10/2006
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
09/2006
1beta CateninIBA
09/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2006
1ManganeseIBA
06/2006
1p-Aminosalicylic Acid (PAS)FDA Link
06/2006
1Ethanol (Ethyl Alcohol)IBA
05/2006
1NF-kappa B (NF-kB)IBA
05/2006
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
04/2006
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
04/2006
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
06/2005
1Antisense OligonucleotidesIBA
02/2005
1telomerase RNA (bTR)IBA
02/2005
1EndostatinsIBA
01/2005
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2005
1Matrix Metalloproteinase 12IBA
01/2005

Therapy/Procedure

2Lasers (Laser)
12/2007 - 01/2004
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2007 - 11/2002
2Drug Therapy (Chemotherapy)
05/2005 - 04/2004
1Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2007
1Conformal Radiotherapy
11/2007
1Pneumonectomy (Lung Volume Reduction)
04/2007
1Transplantation (Transplant Recipients)
01/2007
1Intrauterine Devices (Intrauterine Device)
11/2006
1Tibetan Traditional Medicine (Traditional Tibetan Medicine)
05/2006
1Lung Transplantation
08/2005
1Heterologous Transplantation (Xenotransplantation)
02/2005